Soma Jobbagy, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrasma | 1 | 2024 | 2 | 0.930 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2024 | 1163 | 0.900 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.880 |
Why?
|
| Vulvar Diseases | 1 | 2024 | 64 | 0.870 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2024 | 125 | 0.820 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2020 | 385 | 0.820 |
Why?
|
| Sarcoma, Synovial | 1 | 2022 | 157 | 0.710 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 2020 | 20 | 0.680 |
Why?
|
| Dizziness | 1 | 2023 | 268 | 0.660 |
Why?
|
| Glutathione Reductase | 1 | 2018 | 25 | 0.640 |
Why?
|
| Hamartoma | 1 | 2021 | 235 | 0.620 |
Why?
|
| beta Catenin | 1 | 2024 | 1046 | 0.620 |
Why?
|
| Consciousness Disorders | 1 | 2023 | 445 | 0.590 |
Why?
|
| Lithium | 1 | 2020 | 599 | 0.540 |
Why?
|
| Glutathione | 1 | 2018 | 588 | 0.520 |
Why?
|
| Chest Pain | 1 | 2021 | 1102 | 0.440 |
Why?
|
| Immunohistochemistry | 1 | 2024 | 11030 | 0.350 |
Why?
|
| Heart Ventricles | 1 | 2021 | 3833 | 0.310 |
Why?
|
| Heart Diseases | 1 | 2021 | 2818 | 0.290 |
Why?
|
| Vulva | 1 | 2024 | 84 | 0.220 |
Why?
|
| Diagnosis, Differential | 3 | 2024 | 12973 | 0.220 |
Why?
|
| Vertigo | 1 | 2023 | 205 | 0.180 |
Why?
|
| Pruritus | 1 | 2024 | 376 | 0.180 |
Why?
|
| Nasal Cavity | 1 | 2022 | 309 | 0.170 |
Why?
|
| Cyclooxygenase 1 | 1 | 2020 | 98 | 0.170 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2141 | 0.160 |
Why?
|
| Glutathione Disulfide | 1 | 2018 | 32 | 0.160 |
Why?
|
| Aquaporin 2 | 1 | 2020 | 125 | 0.160 |
Why?
|
| Alkylation | 1 | 2018 | 84 | 0.160 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2020 | 318 | 0.160 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2018 | 105 | 0.150 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2018 | 13 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2018 | 198 | 0.140 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2017 | 17 | 0.140 |
Why?
|
| Sulfhydryl Compounds | 1 | 2018 | 296 | 0.140 |
Why?
|
| Catalysis | 1 | 2018 | 766 | 0.140 |
Why?
|
| Catalytic Domain | 1 | 2018 | 698 | 0.130 |
Why?
|
| Cyclic GMP | 1 | 2017 | 394 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 2219 | 0.120 |
Why?
|
| Biomimetics | 1 | 2016 | 168 | 0.120 |
Why?
|
| Acyltransferases | 1 | 2016 | 305 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 1609 | 0.110 |
Why?
|
| Kinetics | 1 | 2018 | 6273 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2158 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2141 | 0.090 |
Why?
|
| Immunoconjugates | 1 | 2018 | 976 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 1086 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2021 | 4498 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3684 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14450 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2016 | 1411 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3140 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 13398 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3560 | 0.070 |
Why?
|
| Mice | 5 | 2020 | 81782 | 0.070 |
Why?
|
| Humans | 12 | 2024 | 765926 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2307 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 7473 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5695 | 0.060 |
Why?
|
| Female | 5 | 2024 | 396141 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7073 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22327 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5836 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7847 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2023 | 6870 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 2020 | 5128 | 0.050 |
Why?
|
| Aged | 3 | 2024 | 171163 | 0.050 |
Why?
|
| Animals | 5 | 2020 | 168735 | 0.050 |
Why?
|
| Male | 4 | 2024 | 363815 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2022 | 665 | 0.040 |
Why?
|
| Adult | 2 | 2024 | 223088 | 0.040 |
Why?
|
| Middle Aged | 2 | 2024 | 223016 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 14064 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10843 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81537 | 0.040 |
Why?
|
| Proteinuria | 1 | 2020 | 606 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2018 | 23597 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1011 | 0.030 |
Why?
|
| Benzoates | 1 | 2017 | 213 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1763 | 0.030 |
Why?
|
| Child | 1 | 2022 | 80568 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2053 | 0.030 |
Why?
|
| Myocarditis | 1 | 2021 | 803 | 0.030 |
Why?
|
| Vasodilation | 1 | 2017 | 969 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2017 | 1494 | 0.020 |
Why?
|
| Aorta | 1 | 2017 | 2040 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2492 | 0.020 |
Why?
|
| Echocardiography | 1 | 2021 | 5040 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4213 | 0.020 |
Why?
|
| Myocardium | 1 | 2021 | 4764 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2021 | 6409 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4257 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13614 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4856 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10727 | 0.020 |
Why?
|
| Lung | 1 | 2022 | 10046 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29890 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18962 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 23708 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 30192 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18292 | 0.010 |
Why?
|